35 results on '"Tseng, Y.D."'
Search Results
2. Craniospinal Irradiation for CNS Leukemia: Rates of Response and Durability of CNS Control
3. Dosimetric Impact of Radiolucent Carbon Fiber Hardware for Post-Operative Spine Stereotactic Body Radiation Therapy
4. Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphomas: An ILROG Multi-Institutional Study
5. Impact of Myc-Altered Pathology on Radiotherapy Efficacy among Patients with Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Retrospective Study
6. Effect of Lung Blocks Parameters on Lung and Cardiac Doses in Total Body Irradiation Using 3D Dosimetry
7. Single Fraction Radiotherapy as Postoperative Treatment (SF-PORT) for Resected, Stage I/II Merkel Cell Carcinoma
8. Pilot Prognostic Model for Survival in r/r DLBCL Patients Receiving Palliative Radiation Therapy
9. Selection of Mediastinal Lymphoma Patients for Proton Therapy in a Prospective Multi-Institutional Registry: Concordance with the ILROG Guidelines
10. Primary Tumor Location As a Potential Risk Factor for Local Recurrence in Resected, Low-risk Merkel Cell Carcinoma: Implications for Postoperative Radiotherapy
11. Radiation-Induced Brain Injury In Meningioma Patients Treated With Proton Or Photon Therapy
12. Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Amongst Radiation Oncology Residents
13. Importance of Timely Patient Evaluation for Palliative Radiotherapy: A Survey-based Study of Referring Oncologists’ Expectations for Palliative Radiotherapy
14. A Prospective Multi-Institutional Study of Clinical Outcomes for Meningioma Patients Treated with Proton Beam Radiotherapy
15. Learning from our Mistakes: Enhancing Radiation Oncology Residents’ Physics Education with an Incident Learning System
16. Curative Intent Radiation Therapy Delivered Within the Last Year of Life
17. Safety and Efficacy of Proton Beam Therapy for High-Grade Glioma: Initial Report From the Proton Collaborative Group (PCG)
18. Impact of Double/Triple Hit Lymphoma on Radiation Therapy Efficacy Among Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
19. Comparative Photon and Proton Dosimetry for Patients with Mediastinal Lymphoma in the Era of Monte Carlo Treatment Planning and Variable RBE
20. Proton Therapy for Lymphoma: A Multi-institutional Patterns of Care Study
21. Effect of Immune Status on Outcomes and Response to Radiation Among Merkel Cell Carcinoma Patients
22. Use of Radiation Within the Last Year of Life Among Cancer Patients
23. Rates of Toxicity and Outcomes After Mediastinal Proton Therapy For Relapsed/Refractory Lymphoma
24. Four-Dimensional Computer Tomography Scans for Conformal Thoracic Treatment Planning: Is a Single Scan Sufficient to Capture Thoracic Tumor Motion?
25. Clinical Impact of Spatial Variations in Proton Relative Biological Effectiveness (RBE) Among Patients Receiving Radiation to the Prostate and Thorax
26. Interfractional Geometric Variations in Gastrointestinal Organs-at-Risk: Implications for Planning Organs-at-Risk and Hypofractionated Proton Therapy
27. The Use of Consolidative Proton Therapy After First-Line Therapy Among Patients With Hodgkin Lymphoma at Academic and Community Proton Centers
28. Role of Postoperative Radiation Therapy in Stage IA Merkel Cell Carcinoma of the Head and Neck
29. Role of Postoperative Radiation Therapy in Favorable Stage IA Merkel Cell Carcinoma
30. Proton Radiation Therapy for Pediatric Craniopharyngioma
31. Association Between Breast Cancer Biological Subtype and Risk of Locoregional Recurrence A Mastectomy in Node-Negative Patients
32. How Radiation Oncologists Evaluate and Incorporate Life Expectancy Estimates Into the Palliative Treatment of Cancer Patients: A Survey-Based Study
33. Rates and Durability of Response to Salvage Radiation Therapy Among Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma
34. Dosimetric and Clinical Predictors of Nausea and Vomiting: An Exploratory Analysis of a Prospective Phase I/II Trial With Neoadjuvant Accelerated Short Course Radiation Therapy With Capecitabine for Resectable Pancreatic Cancer
35. Post-Treatment Prostate-Specific Antigen Nadir is Predictive of All-Cause Mortality: A Reanalysis of the Dana Farber Cancer Institute Radiation With or Without Androgen Deprivation Therapy Randomized Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.